Obraz kliniczny boreliozy z Lyme

• Autorzy: Flisiak R , Prokopowicz D.
• Języki publikacji: PL

Abstrakty

EN

Prevalence of Lyme borreliosis in Europe has been well esablished during the last decade. The highest morbidity in Poland, exceeding 100 cases (100.000) year, was demonstrated in north-estern part of the country. Additional small endemic areas were also described in south-western and central part of the country. Clinical picture of the disease do not differ significantly from observed in other parts of Europe. Lyme borreliosis is characterized with a wide variety of manifestations recognized as typical: erythema migrans, borrelial lymphocytoma, acrodermatitis chronica atrophicans, arthritis, facial palsy, lymphocytic meningitis and cardiac transduction disturbances. However there are also controversial syndroms, that have confinned etiology of Borrelia burgdorferi but only in some cases, such as: morphea sclerodermatous lesions, cardiomyopathy and some neurologic disorders. Diagnosis of Lyme borreliosis is still based on typical signs of the disease and laboratory techniques can not solve clinical doubts.

Słowa kluczowe

PL

choroby pasozytnicze; choroby czlowieka; badania kliniczne; parazytologia; borelioza

• Wydawca: -
• Czasopismo: Wiadomości Parazytologiczne
• Rocznik: 1999
• Tom: 45
• Numer: 2
• Opis fizyczny: s.143-149,tab.,bibliogr.

Twórcy

autor

Flisiak R

• Akademia Medyczna, ul.Zurawia 14, 15-540 Bialystok

autor

Prokopowicz D.

Bibliografia

• ABELE D.C., ANDERS K.H. 1990. The many faces and phases of borreliosis. J. Am. Acad. Dermatol. 23: 401-408.
• ASBRINK E. 1991. Cuaneous manifestations of Lyme borreliosis. Scand. J. Infect. Dis. suppl. 77: 44-50.
• BARANTON G. i wsp. 1992. Delineation of Borrelia burgdorferi sensu stricto, Borrelia garini sp. nov., and group WS461 associated with Lymne borreliosis. Int. J. Syst. Bacteriol. 42: 378-383.
• BARBOUR A.G., HAYES S.F. 1986. Biology of Borrelia species. Microbiol. Rev. 50: 381-400.
• BURGDORFER W. i wsp. 1982. Lymne disease - a tick - borne spirochetosis? Science 216: 1317-1319.
• COYLE P.K., LUFT B.J. 1995. Managment of Lyme disease. Curr. Opinion Infect. Dis. 8: 444-449.
• FLISIAK R. i wsp. 1994. Zagrożenie endemiczne Boreliozą z Lyme w regionie Puszczy Białowieskiej. Przegl. Epidemiol. 48: 211-217.
• FLISIAK R., ŻABICKA J. 1995. Sytuacja epidemiologiczna boreliozy z Lyme w Europie. Przegl. Epidemiol. 49: 373-379.
• FLISIAK R., PROKOPOWICZ D. 1996. Charakterystyka epidemiologiczno-kliniczna Boreliozy z Lyme w regionie północno-wschodnim Polski. Pol. Tyg. Lek. 51: 326-328.
• GOLDE W. T. 2998. A vaccine for Lyme disease: current progress. Infect. Med. 15: 38-44.
• HALPERIN J.J. 1995. Neuroborreliosis. Am. J. Med. 98 (suppl. 4 A): 52-56.
• VAN DER LINDE M.R. 1991. Lyme carditis: clinical characteristics of 105 cases. Scand. J. Infect. Dis., suppl. 77: 81-85.
• MALANE M.S. i wsp. 1991. Diagnosis of Lyme disease based on dermatologic manifestations. Ann. Intern. Med. 114: 490-498.
• RAHN D. W., MALAWISTA S.E. 1991. Lyme disease: recommendations for diagnosis and treatment. Ann. Intern. Med. 114: 472-481.
• SIUDA K. 1993. Kleszcze Polski. PTP, Warszawa, 234.
• STEERE A.C. 1989. Lyme disease. N. Engl. J. Med. 321: 586-596.
• STEERE A.C. 1991. Clinical definition and differential diagnosis of Lyme arthritis. Scand. J. Infect. Dis. Suppl. 77: 51-54.
• STROBINO B.A. i wsp. 1993. Lyme disease and pregnancy outcome: a prospective study of two thousant prenatal patients. Am. J. Obstet. Gynecol. 169: 367-374.